You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: June 2023 to September 2025

AbstractFullPdf
Jun 2023831842225
Jul 202340640886
Aug 202337938192
Sep 202325425668
Oct 202324524576
Nov 202334634782
Dec 202325125474
Jan 202423323687
Feb 202421221459
Mar 2024274276181
Apr 2024293293100
May 202424024070
Jun 202426226275
Jul 202428328459
Aug 202419419343
Sep 202422622755
Oct 202424624654
Nov 202424724862
Dec 202425526276
Jan 202520220374
Feb 202516216691
Mar 202522622668
Apr 202522822879
May 202521521784
Jun 202512012245
Jul 2025110
Sep 2025220
Total683368792065